Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Finke

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
Leukemia|January 31, 2014
CALR mutations are infrequent in WHO-defined refractory anemia with ring sideroblastsM M Patnaik, A Belachew, C Finke, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 1, 1997
[The demonstration of the radiation-induced production of tumor necrosis factor-alpha in Ewing's sarcoma RM 82 in vitro and in vivo]C Rübe, C Finke, F van Valen, et al.
Leukemia|January 16, 2013
Increased circulating IL-2Rα (CD25) predicts poor outcome in both indolent and aggressive forms of mastocytosis: a comprehensive cytokine-phenotype studyA Pardanani, C Finke, R A Abdelrahman, et al.
Blood Cancer Journal|June 18, 2016
Leukocytosis and presence of CALR mutation is associated with non-hepatosplenic extramedullary hematopoiesis in primary myelofibrosisD Barraco, T L Lasho, N Gangat, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 31, 2023
An unusual case of checkpoint-inhibitor-induced pleuropericarditisZoilo K Suarez, Ana C Finke, Emilio Hospedales, et al.
Leukemia|April 27, 2007
JAK2V617F prevalence and allele burden in non-splanchnic venous thrombosis in the absence of overt myeloproliferative disorderA Pardanani, T L Lasho, S Schwager, et al.
Leukemia|November 2, 2017
Prognostic significance of ASXL1 mutation types and allele burden in myelofibrosisA Tefferi, T L Lasho, C Finke, et al.
Leukemia|September 14, 2011
IPSS-independent prognostic value of plasma CXCL10, IL-7 and IL-6 levels in myelodysplastic syndromesA Pardanani, C Finke, T L Lasho, et al.
The Journal of Orthopaedic and Sports Physical Therapy|January 1, 1988
Shoulder injuries in ice hockeyR C Finke, S Goodwin Gerberich, M Madden, et al.
Medicine|September 30, 2016
Early risk prognosis of free-flap transplant failure by quantitation of the macrophage colony-stimulating factor in patient plasma using 2-dimensional liquid-chromatography multiple reaction monitoring-mass spectrometryJingzhi Yang, Juliane C Finke, Juncong Yang, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Leukemia|January 31, 2014
CALR mutations are infrequent in WHO-defined refractory anemia with ring sideroblastsM M Patnaik, A Belachew, C Finke, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 1, 1997
[The demonstration of the radiation-induced production of tumor necrosis factor-alpha in Ewing's sarcoma RM 82 in vitro and in vivo]C Rübe, C Finke, F van Valen, et al.
Leukemia|January 16, 2013
Increased circulating IL-2Rα (CD25) predicts poor outcome in both indolent and aggressive forms of mastocytosis: a comprehensive cytokine-phenotype studyA Pardanani, C Finke, R A Abdelrahman, et al.
Blood Cancer Journal|June 18, 2016
Leukocytosis and presence of CALR mutation is associated with non-hepatosplenic extramedullary hematopoiesis in primary myelofibrosisD Barraco, T L Lasho, N Gangat, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 31, 2023
An unusual case of checkpoint-inhibitor-induced pleuropericarditisZoilo K Suarez, Ana C Finke, Emilio Hospedales, et al.
Leukemia|April 27, 2007
JAK2V617F prevalence and allele burden in non-splanchnic venous thrombosis in the absence of overt myeloproliferative disorderA Pardanani, T L Lasho, S Schwager, et al.
Leukemia|November 2, 2017
Prognostic significance of ASXL1 mutation types and allele burden in myelofibrosisA Tefferi, T L Lasho, C Finke, et al.
Leukemia|September 14, 2011
IPSS-independent prognostic value of plasma CXCL10, IL-7 and IL-6 levels in myelodysplastic syndromesA Pardanani, C Finke, T L Lasho, et al.
The Journal of Orthopaedic and Sports Physical Therapy|January 1, 1988
Shoulder injuries in ice hockeyR C Finke, S Goodwin Gerberich, M Madden, et al.
Medicine|September 30, 2016
Early risk prognosis of free-flap transplant failure by quantitation of the macrophage colony-stimulating factor in patient plasma using 2-dimensional liquid-chromatography multiple reaction monitoring-mass spectrometryJingzhi Yang, Juliane C Finke, Juncong Yang, et al.
Pageof 7